FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:2060-2062 May 11, 2006 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Brown, K. M. PubMed Citation

The characteristics of renal allografts before transplantation present a multifaceted puzzle that in large part predetermines the outcome of kidney transplantation. Compatibility at the major-histocompatibility-complex (MHC) loci, the age of the donor, cold-ischemia times, and nephron mass^1,2 all contribute to long-term results through interacting effects involving initial damage to parenchymal or vascular cells and possible hyperfiltration. Many factors are involved in chronic allograft dysfunction, in which immune-mediated lesions caused by chronic rejection are only one component.³

In this issue of the Journal, Brown et al.⁴ report on a newly identified donor factor, an allotype of the C3 complement molecule that . . . [Full Text of this Article]

Source Information

From the Centre Hospitalier Universitaire de Nantes and INSERM Unité 643 (J.-P.S., M.G.) and Université de Nantes (J.-P.S.) — all in Nantes, France.

This article has been cited by other articles:

• Varagunam, M., Yaqoob, M. M., Dohler, B., Opelz, G. (2009). C3 Polymorphisms and Allograft Outcome in Renal Transplantation. NEJM 360: 874-880 [Abstract] [Full Text]  
• von Herrath, M. (2009). Can We Learn From Viruses How to Prevent Type 1 Diabetes?: The Role of Viral Infections in the Pathogenesis of Type 1 Diabetes and the Development of Novel Combination Therapies. Diabetes 58: 2-11 [Abstract] [Full Text]